Practical Fragments

This blog is meant to allow Fragment-based Drug Design Practitioners to get together and discuss NON-CONFIDENTIAL issues regarding fragments.

29 October 2017

On Par with the Pyramids... a New Book on Drug Discovery!

›
There are many great testaments to humanity's perseverance.   The Pyramids at Giza , the Cathedral of Notre Dame , the Great Wall of Chi...
23 October 2017

Poll results: does your primary fragment library contain racemates?

›
Our latest poll asked just this question. We received 72 responses, and the results are shown here. Almost half of respondents said ...
16 October 2017

Docking for finding and optimizing fragments

›
Docking can sometimes seem like the Rodney Dangerfield of FBDD: it don’t get no respect. In last year’s poll of fragment finding methods,...
1 comment:
09 October 2017

Fragments vs ketohexokinase (KHK) deliver a chemical probe

›
Anyone who has paid any attention to health news will be aware of concerns over high fructose corn syrup . Just a few years ago the stuff w...
02 October 2017

Dynamic combinatorial chemistry revisited: why it’s so difficult

›
Last year we discussed the application of dynamic combinatorial chemistry ( DCC ) to fragment linking. The idea is that a protein will shif...
25 September 2017

Flipping fragments in CDK8

›
The cyclin-dependent kinases ( CDKs ) are targets for a variety of diseases, particularly cancers. One of the earliest posts at Practical ...
18 September 2017

Fragment linking to a selective CK2 inhibitor

›
The kinase CK2 is an intriguing anti-cancer target, but most of the reported inhibitors bind in the conserved hinge region and so also hi...
11 September 2017

Chiral fragments – and poll!

›
Chirality underpins all life. Nineteen of the twenty amino acids contain at least one stereocenter , as do all nucelosides, sugars, and mo...
04 September 2017

Efficiently searching for fragments

›
What do you do when you find a fragment? After checking for artifacts and getting as much structural information as possible, the next ste...
28 August 2017

Fragments vs BET Bromodomains: FORMA’s story

›
Five years ago Teddy highlighted a paper from GlaxoSmithKline that reported the discovery and characterization of several different fragme...
20 August 2017

Fragments vs histone KDM4 lysine demethylases: Celgene’s story

›
Last year we highlighted a paper from academia in which modeling was used to discover potent inhibitors of the lysine demethylase KDM4C, a...
14 August 2017

Fragments distinguish allosteric from active site binders

›
As discussed last year, secondary binding sites on proteins appear to be quite common. Some of these sites have no functional relevance, b...
07 August 2017

Assessing ligandability by thermal scanning

›
Ligandability refers to the ability to find small-molecule leads against a target. A protein might be ligandable but not druggable if, for...
2 comments:
31 July 2017

Fragments in the clinic: PF-06650833

›
Of the more than 30 fragment-derived drugs that have entered clinical development , more than a third target kinases. While most of these a...
1 comment:
24 July 2017

Fragments vs Trypanosoma parasites

›
Last month we highlighted how fragments could be used to discover inhibitors of protein-protein interactions (PPIs). Today we continue the...
1 comment:
17 July 2017

Native mass spectrometry revisited

›
Native electrospray ionization mass spectrometry (ESI-MS) is one of the less-commonly used fragment finding methods . The technique relies ...
2 comments:
10 July 2017

Reagents as covalent fragments

›
Covalent drugs are a thing these days: as long as you can get selectivity, there’s nothing like a covalent bond to juice up affinity for a ...
3 comments:
03 July 2017

Fragment events in 2017 and 2018

›
The year is halfway behind us, but there are still a couple upcoming fragment-based events, and next year is already taking shape. 2017 ...
1 comment:
26 June 2017

Fragments vs BCL6, two ways

›
Disrupting protein-protein interactions (PPIs) tends to be challenging: interfaces are often large and flat, with few deep pockets in which...
1 comment:
19 June 2017

Fragments vs BRD4, two ways

›
Bromodomains, epigenetic targets that recognize acetylated lysine residues, have received considerable attention from the fragment communit...
1 comment:
‹
›
Home
View web version
Powered by Blogger.